Skip to main content
SpringerLink
Log in

Atopic Dermatitis and Eczematous Eruptions

  • Chapter
  • First Online:
Therapy in Pediatric Dermatology

  • 1494 Accesses

Abstract

Eczematous eruptions are very common in children. Atopic dermatitis affects 10–20 % of children in several industrialized countries and is increasing in prevalence in many parts of the world. This chapter outlines the evaluation and evidenced-based treatment of atopic dermatitis as well as other common eczematous conditions including: pityriasis alba, contact dermatitis, juvenile plantar dermatosis, nummular dermatitis, lichen striatus, lichen simplex chronicus, and seborrheic dermatitis.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 299.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Paller AS, Mancini AJ. Hurwitz clinical pediatric dermatology: a textbook of skin disorders of childhood and adolescence. Philadelphia: Elsevier Health Sciences; 2011. p. 3568.

    Google Scholar 

  2. Irvine AD, Hoeger PH, Yan AC. Harper’s textbook of pediatric dermatology, 2 volume set. Hoboken: Wiley; 2011. p. 7719.

    Book  Google Scholar 

  3. Schachner LA, Hansen RC. Pediatric dermatology. Philadelphia: Elsevier Health Sciences; 2011. p. 10363.

    Google Scholar 

  4. Lewis-Jones S. Quality of life and childhood atopic dermatitis: the misery of living with childhood eczema. Int J Clin Pract. 2006;60(8):984–92.

    Article  CAS  PubMed  Google Scholar 

  5. Beattie PE, Lewis-Jones MS. A comparative study of impairment of quality of life in children with skin disease and children with other chronic childhood diseases. Br J Dermatol. 2006;155(1):145–51.

    Article  CAS  PubMed  Google Scholar 

  6. Yaghmaie P, Koudelka CW, Simpson EL. Mental health comorbidity in patients with atopic dermatitis. J Allergy Clin Immunol. 2013;131(2):428–33.

    Article  PubMed  Google Scholar 

  7. Hanifin JM, Rajka G. Diagnostic features of atopic eczema. Acta Dermatol Venereol Stockh. 1980;92:44–7.

    Google Scholar 

  8. Eichenfield LF, Tom WL, Chamlin SL, Feldman SR, Hanifin JM, Simpson EL, et al. Guidelines of care for the management of atopic dermatitis: section 1. Diagnosis and assessment of atopic dermatitis. J Am Acad Dermatol. 2014;70(2):338–51.

    Article  PubMed  Google Scholar 

  9. Panel N-SE. Guidelines for the diagnosis and management of food allergy in the United States: report of the NIAID-sponsored expert panel. J Allergy Clin Immunol. 2010;126(6):S1–58.

    Article  Google Scholar 

  10. Williams HC. Established corticosteroid creams should be applied only once daily in patients with atopic eczema. Br Med J. 2007;334:1272.

    Article  Google Scholar 

  11. Hajar T, Hanifin JM, Tofte SJ, Simpson EL. Pre-hydration is effective for rapid control of recalcitrant atopic dermatitis. Dermatol Contact Atopic Occup Drug. 2014;25(2):56–9.

    CAS  Google Scholar 

  12. Thomas KS, Armstrong S, Avery A, Po ALW, O’Neill C, Young S, et al. Randomised controlled trial of short bursts of a potent topical corticosteroid versus prolonged use of a mild preparation for children with mild or moderate atopic eczema. BMJ. 2002;324(7340):768.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Eichenfield LF, Tom WL, Berger TG, Krol A, Paller AS, Schwarzenberger K, et al. Guidelines of care for the management of atopic dermatitis: section 2. Management and treatment of atopic dermatitis with topical therapies. J Am Acad Dermatol. 2014;71(1):116–32.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Callen J, Chamlin S, Eichenfield LF, Ellis C, Girardi M, Goldfarb M, et al. A systematic review of the safety of topical therapies for atopic dermatitis. Br J Dermatol. 2007;156(2):203–21.

    Article  CAS  PubMed  Google Scholar 

  15. Gober L, Spergel JM. Intermittent therapy for flare prevention and long-term disease control in stabilized atopic dermatitis: a randomized comparison of 3-times-weekly applications of tacrolimus ointment versus vehicle. Pediatrics. 2009;124(Supplement 2):S131–2.

    Article  Google Scholar 

  16. Paller AS, Eichenfield LF, Kirsner RS, Shull T, Jaracz E, Simpson EL, et al. Three times weekly tacrolimus ointment reduces relapse in stabilized atopic dermatitis: a new paradigm for use. Pediatrics. 2008;122(6):e1210–8.

    Article  PubMed  Google Scholar 

  17. Huang JT, Abrams M, Tlougan B, Rademaker A, Paller AS. Treatment of Staphylococcus aureus colonization in atopic dermatitis decreases disease severity. Pediatrics. 2009;123(5):e808–14.

    Article  PubMed  Google Scholar 

  18. Sidbury R, Sullivan AF, Thadhani RI, Camargo CA. Randomized controlled trial of vitamin D supplementation for winter-related atopic dermatitis in Boston: a pilot study. Br J Dermatol. 2008;159(1):245–7.

    Article  CAS  PubMed  Google Scholar 

  19. Klein PA, Clark RF. An evidence-based review of the efficacy of antihistamines in relieving pruritus in atopic dermatitis. Arch Dermatol. 1999;135(12):1522–5.

    Article  CAS  PubMed  Google Scholar 

  20. Lee KC, Keyes A, Hensley JR, Gordon JR, Kwasny MJ, West DP, et al. Effectiveness of acupressure on pruritus and lichenification associated with atopic dermatitis: a pilot trial. Acupunct Med. 2012;30(1):8–11.

    Google Scholar 

  21. Sidbury R, Davis DM, Cohen DE, Cordoro KM, Berger TG, Bergman JN, et al. Guidelines of care for the management of atopic dermatitis: section 3. Management and treatment with phototherapy and systemic agents. J Am Acad Dermatol. 2014;71(2):327–49.

    Article  PubMed  PubMed Central  Google Scholar 

  22. Schneider L, Tilles S, Lio P, Boguniewicz M, Beck L, LeBovidge J, et al. Atopic dermatitis: a practice parameter update 2012. J Allergy Clin Immunol. 2013;131(2):295–9.

    Article  PubMed  Google Scholar 

  23. Schmitt J, von Kobyletzki L, Svensson AA, Apfelbacher C. Efficacy and tolerability of proactive treatment with topical corticosteroids and calcineurin inhibitors for atopic eczema: systematic review and meta-analysis of randomized controlled trials. Br J Dermatol. 2011;164(2):415–28.

    Article  CAS  PubMed  Google Scholar 

  24. Schmitt J, Schmitt N, Meurer M. Cyclosporin in the treatment of patients with atopic eczema–a systematic review and meta-analysis. J Eur Acad Dermatol Venereol. 2007;21(5):606–19.

    CAS  PubMed  Google Scholar 

  25. Haw S, Shin M-K, Haw C-R. The efficacy and safety of long-term oral cyclosporine treatment for patients with atopic dermatitis. Ann Dermatol. 2010;22(1):9–15.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. El-Khalawany MA, Hassan H, Shaaban D, Ghonaim N, Eassa B. Methotrexate versus cyclosporine in the treatment of severe atopic dermatitis in children: a multicenter experience from Egypt. Eur J Pediatr. 2013;172(3):351–6.

    Article  CAS  PubMed  Google Scholar 

  27. Haeck IM, Knol MJ, ten Berge O, van Velsen SG, de Bruin-Weller MS, Bruijnzeel-Koomen CA. Enteric-coated mycophenolate sodium versus cyclosporin A as long-term treatment in adult patients with severe atopic dermatitis: a randomized controlled trial. J Am Acad Dermatol. 2011;64(6):1074–84.

    Article  CAS  PubMed  Google Scholar 

  28. Schram ME, Roekevisch E, Leeflang MMG, Bos JD, Schmitt J, Spuls PI. A randomized trial of methotrexate versus azathioprine for severe atopic eczema. J Allergy Clin Immunol. 2011;128(2):353–9.

    Article  CAS  PubMed  Google Scholar 

  29. Hanifin JM, Schneider LC, Leung DY, Ellis CN, Jaffe HS, Izu AE, et al. Recombinant interferon gamma therapy for atopic dermatitis. J Am Acad Dermatol. 1993;28(2):189–97.

    Article  CAS  PubMed  Google Scholar 

  30. Silverberg NB. Pityriasis alba. In: Irvine AD, Hoeger PH, Yan AC, editors. Harper’s textbook of pediatric dermatology [Internet]. Hoboken: Wiley-Blackwell; 2011. p. 37.1–3. Available from: http://onlinelibrary.wiley.com/doi/10.1002/9781444345384.ch37/summary.

    Google Scholar 

  31. Lin RL, Janniger CK. Pityriasis alba. Cutis. 2005;76(1):21–4.

    PubMed  Google Scholar 

  32. Bassaly M, Miale Jr A, Prasad AS. Studies on pityriasis alba: a common facial skin lesion in Egyptian children. Arch Dermatol. 1963;88(3):272–5.

    Article  CAS  PubMed  Google Scholar 

  33. Blessmann Weber M, Sponchiado de Avila LG, Albaneze R, Magalhães de Oliveira OL, Sudhaus BD, Ferreira Cestari T. Pityriasis alba: a study of pathogenic factors. J Eur Acad Dermatol Venereol. 2002;16(5):463–8.

    Article  CAS  PubMed  Google Scholar 

  34. İnanir I, Sahin MT, Gündüz K, Dinç G, Türel A, Oztürkcan S. Prevalence of skin conditions in primary school children in Turkey: differences based on socioeconomic factors. Pediatr Dermatol. 2002;19(4):307–11.

    Article  PubMed  Google Scholar 

  35. In SI, Yi SW, Kang HY, Lee ES, Sohn S, Kim YC. Clinical and histopathological characteristics of pityriasis alba. Clin Exp Dermatol. 2009;34(5):591–7.

    Article  CAS  PubMed  Google Scholar 

  36. Whitmore SE, Simmons-O’Brien E, Rotter FS. Hypopigmented mycosis fungoides. Arch Dermatol. 1994;130(4):476–80.

    Article  CAS  PubMed  Google Scholar 

  37. Vinod S, Singh G, Dash K, Grover S. Clinico epidemiological study of pityriasis alba. Indian J Dermatol Venereol Leprol. 2002;68(6):338.

    PubMed  Google Scholar 

  38. Wells BT, Whyte HJ, Kierland RR. Pityriasis alba: a ten-year survey and review of the literature. Arch Dermatol. 1960;82(2):183–9.

    Article  CAS  PubMed  Google Scholar 

  39. Rigopoulos D, Gregoriou S, Charissi C, Kontochristopoulos G, Kalogeromitros D, Georgala S. Tacrolimus ointment 0.1% in pityriasis alba: an open-label, randomized, placebo-controlled study. Br J Dermatol. 2006;155(1):152–5.

    Article  CAS  PubMed  Google Scholar 

  40. Moreno-Cruz B, Torres-Alvarez B, Hernández-Blanco D, Castanedo-Cazares JP. Double-blind, placebo-controlled, randomized study comparing 0.0003% calcitriol with 0.1% tacrolimus ointments for the treatment of endemic pityriasis alba. Dermatol Res Pract [Internet]. 2012 [cited 14 Oct 2015];2012. Available from: http://www.hindawi.com/journals/drp/2012/303275/abs/.

  41. Fujita WH, McCormick CL, Parneix-Spake A. An exploratory study to evaluate the efficacy of pimecrolimus cream 1% for the treatment of pityriasis alba. Int J Dermatol. 2007;46(7):700–5.

    Article  CAS  PubMed  Google Scholar 

  42. Al-Mutairi N, Hadad AA. Efficacy of 308-nm xenon chloride excimer laser in pityriasis alba. Dermatol Surg. 2012;38(4):604–9.

    Article  CAS  PubMed  Google Scholar 

  43. Zaynoun S, Jaber LA, Kurban AK. Oral methoxsalen photochemotherapy of extensive pityriasis alba. Preliminary report. J Am Acad Dermatol. 1986;15(1):61–5.

    Article  CAS  PubMed  Google Scholar 

  44. Militello G, Jacob SE, Crawford GH. Allergic contact dermatitis in children. Curr Opin Pediatr. 2006;18(4):385–90.

    Article  PubMed  Google Scholar 

  45. Saary J, Qureshi R, Palda V, DeKoven J, Pratt M, Skotnicki-Grant S, et al. A systematic review of contact dermatitis treatment and prevention. J Am Acad Dermatol. 2005;53(5):845–e1.

    Article  PubMed  Google Scholar 

  46. Simonsen AB, Deleuran M, Mortz CG, Johansen JD, Sommerlund M. Allergic contact dermatitis in Danish children referred for patch testing–a nationwide multicentre study. Contact Dermatitis. 2014;70(2):104–11.

    Article  PubMed  Google Scholar 

  47. Hogeling M, Pratt M. Allergic contact dermatitis in children: the Ottawa hospital patch-testing clinic experience, 1996 to 2006. Dermatitis. 2008;19(2):86–9.

    CAS  PubMed  Google Scholar 

  48. Zug KA, Pham AK, Belsito DV, DeKoven JG, DeLeo VA, Fowler Jr JF, et al. Patch testing in children from 2005 to 2012: results from the North American contact dermatitis group. Dermatitis. 2014;25(6):345–55.

    Article  PubMed  Google Scholar 

  49. Jacob SE, Brod B, Crawford GH. Clinically relevant patch test reactions in children—a United States based study. Pediatr Dermatol. 2008;25(5):520–7.

    Article  PubMed  Google Scholar 

  50. Alomar A, Puig L, Gallardo CM, Valenzuela N. Topical tacrolimus 0.1% ointment (Protopic®) reverses nickel contact dermatitis elicited by allergen challenge to a similar degree to mometasone furoate 0.1% with greater suppression of late erythema. Contact Dermatitis. 2003;49(4):185–8.

    Article  CAS  PubMed  Google Scholar 

  51. Belsito D, Wilson DC, Warshaw E, Fowler J, Ehrlich A, Anderson B, et al. A prospective randomized clinical trial of 0.1% tacrolimus ointment in a model of chronic allergic contact dermatitis. J Am Acad Dermatol. 2006;55(1):40–6.

    Article  PubMed  Google Scholar 

  52. Katsarou A, Makris M, Papagiannaki K, Lagogianni E, Tagka A, Kalogeromitros D. Tacrolimus 0.1% vs mometasone furoate topical treatment in allergic contact hand eczema: a prospective randomized clinical study. Eur J Dermatol. 2012;22(2):192–6.

    CAS  PubMed  Google Scholar 

  53. Katsarou A, Armenaka M, Vosynioti V, Lagogianni E, Kalogeromitros D, Katsambas A. Tacrolimus ointment 0.1% in the treatment of allergic contact eyelid dermatitis. J Eur Acad Dermatol Venereol. 2009;23(4):382–7.

    Article  CAS  PubMed  Google Scholar 

  54. Queille-Roussel C, Graeber M, Thurston M, Lachapelle J-M, Decroix J, De Cuyper C, et al. SDZ ASM 981 is the first non-steroid that suppresses established nickel contact dermatitis elicited by allergen challenge. Contact Dermatol Environ Occup Dermatol. 2000;42(6):349–50.

    Article  CAS  Google Scholar 

  55. Weston WL, Weston JA. Allergic contact dermatitis in children. Am J Dis Child. 1984;138(10):932–6.

    CAS  PubMed  Google Scholar 

  56. Mørk NJ, Austad J. Short-wave ultraviolet light (UVB) treatment of allergic contact dermatitis of the hands. Acta Derm Venereol. 1982;63(1):87–9.

    Google Scholar 

  57. Rosen K, Mobacken H, Swanbeck G. Chronic eczematous dermatitis of the hands: a comparison of PUVA and UVB treatment. Acta Derm Venereol. 1986;67(1):48–54.

    Google Scholar 

  58. Simons JR, Bohnen I, Van der Valk PGM. A left–right comparison of UVB phototherapy and topical photochemotherapy in bilateral chronic hand dermatitis after 6 weeks’ treatment. Clin Exp Dermatol. 1997;22(1):7–10.

    Article  CAS  PubMed  Google Scholar 

  59. Weston JA, Hawkins K, Weston WL. Foot dermatitis in children. Pediatrics. 1983;72(6):824–7.

    CAS  PubMed  Google Scholar 

  60. Jones SK, English JSC, Forsyth A, Mackie RM. Juvenile Plantar Dermatosis—an 8-year follow-up of 102 patients. Clin Exp Dermatol. 1987;12(1):5–7.

    Article  CAS  PubMed  Google Scholar 

  61. Young E. Forefoot eczema—further studies and a review. Clin Exp Dermatol. 1986;11(6):523–8.

    Article  CAS  PubMed  Google Scholar 

  62. Ashton RE, Jones RR, Griffiths A. Juvenile plantar dermatosis: a clinicopathologic study. Arch Dermatol. 1985;121(2):225–8.

    Article  CAS  PubMed  Google Scholar 

  63. Shipley DR, Kennedy CTC. Juvenile plantar dermatosis responding to topical tacrolimus ointment. Clin Exp Dermatol. 2006;31(3):453–4.

    Article  CAS  PubMed  Google Scholar 

  64. Datz B, Yawalkar S. A double-blind, multicenter trial of 0.05% halobetasol propionate ointment and 0.05% clobetasol 17-propionate ointment in the treatment of patients with chronic, localized atopic dermatitis or lichen simplex chronicus. J Am Acad Dermatol. 1991;25(6):1157–60.

    Article  CAS  PubMed  Google Scholar 

  65. Aschoff R, Wozel G. Topical tacrolimus for the treatment of lichen simplex chronicus. J Dermatol Treat. 2007;18(2):115–7.

    Article  Google Scholar 

  66. Goldstein AT, Parneix-Spake A, McCormick CL, Burrows LJ. Pimecrolimus cream 1% for treatment of vulvar lichen simplex chronicus: an open-label, preliminary trial. Gynecol Obstet Invest. 2007;64(4):180–6.

    Article  CAS  PubMed  Google Scholar 

  67. Bard JW. Flurandrenolone tape in the treatment of lichen simplex chronicus. J Ky Med Assoc. 1969;67(9):668–70.

    CAS  PubMed  Google Scholar 

  68. Yosipovitch G, Sugeng MW, Chan YH, Goon A, Ngim S, Goh CL. The effect of topically applied aspirin on localized circumscribed neurodermatitis. J Am Acad Dermatol. 2001;45(6):910–3.

    Article  CAS  PubMed  Google Scholar 

  69. Drake LA, Millikan LE. The antipruritic effect of 5% doxepin cream in patients with eczematous dermatitis. Doxepin Study Group. Arch Dermatol. 1995;131(12):1403–8.

    Article  CAS  PubMed  Google Scholar 

  70. Thomson KF, Highet AS. 5% Doxepin cream to treat persistent lichenification in a child. Clin Exp Dermatol. 2001;26(1):100.

    Article  CAS  PubMed  Google Scholar 

  71. Shenefelt PD. Biofeedback, cognitive-behavioral methods, and hypnosis in dermatology: is it all in your mind? Dermatol Ther. 2003;16(2):114–22.

    Article  PubMed  Google Scholar 

  72. Rosenbaum MS, Ayllon T. The behavioral treatment of neurodermatitis through habit-reversal. Behav Res Ther. 1981;19(4):313–8.

    Article  CAS  PubMed  Google Scholar 

  73. Heckmann M, Heyer G, Brunner B, Plewig G. Botulinum toxin type A injection in the treatment of lichen simplex: an open pilot study. J Am Acad Dermatol. 2002;46(4):617–9.

    Article  PubMed  Google Scholar 

  74. Jixian L. Treatment of 86 cases of local neurodermatitis by electro-acupuncture (with needles inserted around diseased areas). J Tradit Chin Med [Internet]. 1987 [cited 2 Jun 2015];7(1). Available from: http://cat.inist.fr/?aModele=afficheN&cpsidt=8211086.

  75. Kikindjanin V, Vukaviíc T, Stevanocvić V. Effectiveness of ketotifen in the treatment of neurodermatitis in childhood. Dermatol Monatsschr. 1990;176(12):741–4.

    CAS  PubMed  Google Scholar 

  76. Yang Q. Acupuncture treatment of 139 cases of neurodermatitis. J Tradit Chin Med. 1997;17(1):57–8.

    CAS  PubMed  Google Scholar 

  77. Gencoglan G, Inanir I, Gunduz K. Therapeutic hotline: treatment of prurigo nodularis and lichen simplex chronicus with gabapentin. Dermatol Ther. 2010;23(2):194–8.

    Article  PubMed  Google Scholar 

  78. Taieb A, El Youbi A, Grosshans E, Maleville J. Lichen striatus: a Blaschko linear acquired inflammatory skin eruption. J Am Acad Dermatol. 1991;25(4):637–42.

    Article  CAS  PubMed  Google Scholar 

  79. Kennedy D, Rogers M. Lichen striatus. Pediatr Dermatol. 1996;13(2):95–9.

    Article  CAS  PubMed  Google Scholar 

  80. Jo J-H, Jang H-S, Park H-J, Kim M-B, Oh C-K, Kwon K-S. Early treatment of multiple and spreading lichen striatus with topical tacrolimus. J Am Acad Dermatol. 2007;57(5):904–5.

    Article  PubMed  Google Scholar 

  81. Vukićević J, Milobratović D, Vesić S, Milosević-Jovćić N, Cirić D, Medenica L. Unilateral multiple lichen striatus treated with tacrolimus ointment: a case report. Acta Dermatovenerol Alp Pannonica Adriat. 2009;18(1):35–8.

    PubMed  Google Scholar 

  82. Lee M-W, Choi J-H, Sung K-J, Moon K-C, Koh J-K. Linear eruptions of the nose in childhood: a form of lichen striatus? Br J Dermatol. 2000;142(6):1208–12.

    Article  CAS  PubMed  Google Scholar 

  83. Bettoli V, Tosti A, Varotti C. Nummular eczema during isotretinoin treatment. J Am Acad Dermatol. 1987;16(3 Pt 1):617.

    Article  CAS  PubMed  Google Scholar 

  84. Tanaka T, Satoh T, Yokozeki H. Dental infection associated with nummular eczema as an overlooked focal infection. J Dermatol. 2009;36(8):462–5.

    Article  PubMed  Google Scholar 

  85. Fleming C, Parry E, Forsyth A, Kemmett D. Patch testing in discoid eczema. Contact Dermatitis. 1997;36(5):261–4.

    Article  CAS  PubMed  Google Scholar 

  86. Bonamonte D, Foti C, Vestita M, Ranieri LD, Angelini G. Nummular eczema and contact allergy: a retrospective study. Dermatitis. 2012;23(4):153–7.

    Article  PubMed  Google Scholar 

  87. Volden G. Successful treatment of therapy-resistant atopic dermatitis with clobetasol propionate and a hydrocolloid occlusive dressing. Acta Derm Venereol Suppl Stockh. 1992;176:126–8.

    CAS  PubMed  Google Scholar 

  88. Roberts H, Orchard D. Methotrexate is a safe and effective treatment for paediatric discoid (nummular) eczema: a case series of 25 children. Australas J Dermatol. 2010;51(2):128–30.

    Article  PubMed  Google Scholar 

  89. Wallengren J, Sundler F. Phototherapy reduces the number of epidermal and CGRP-positive dermal nerve fibres. Acta Derm Venereol. 2004;84(2):111–5.

    Article  CAS  PubMed  Google Scholar 

  90. Naldi L, Rebora A. Seborrheic dermatitis. N Engl J Med. 2009;360(4):387–96.

    Article  CAS  PubMed  Google Scholar 

  91. Dessinioti C, Katsambas A. Seborrheic dermatitis: etiology, risk factors, and treatments: facts and controversies. Clin Dermatol. 2013;31(4):343–51.

    Article  PubMed  Google Scholar 

  92. Skinner RB, Noah PW, Taylor RM, Zanolli MD, West S, Guin JD, et al. Double-blind treatment of seborrheic dermatitis with 2% ketoconazole cream. J Am Acad Dermatol. 1985;12(5):852–6.

    Article  PubMed  Google Scholar 

  93. Elewski BE, Abramovits W, Kempers S, Schlessinger J, Rosen T, Gupta AK, et al. A novel foam formulation of ketoconazole 2% for the treatment of seborrheic dermatitis on multiple body regions. J Drugs Dermatol JDD. 2007;6(10):1001–8.

    PubMed  Google Scholar 

  94. Stratigos JD, Antoniou C, Katsambas A, Böhler K, Fritsch P, Schmölz A, et al. Ketoconazole 2% cream versus hydrocortisone 1% cream in the treatment of seborrheic dermatitis: a double-blind comparative study. J Am Acad Dermatol. 1988;19(5):850–3.

    Article  CAS  PubMed  Google Scholar 

  95. Wannanukul S, Chiabunkana J. Comparative study of 2% ketoconazole cream and 1% hydrocortisone cream in the treatment of infantile seborrheic dermatitis. J Med Assoc Thai. 2004;87:S68–71.

    PubMed  Google Scholar 

  96. Green CA, Farr PM, Shuster S. Treatment of seborrhoeic dermatitis with ketoconazole: II. Response of seborrhoeic dermatitis of the face, scalp and trunk to topical ketoconazole. Br J Dermatol. 1987;116(2):217–21.

    Article  CAS  PubMed  Google Scholar 

  97. Peter RU, Richarz-Barthauer U. Successful treatment and prophylaxis of scalp seborrhoeic dermatitis and dandruff with 2% ketoconazole shampoo: results of a multicentre, double-blind, placebo-controlled trial. Br J Dermatol. 1995;132(3):441–5.

    Article  CAS  PubMed  Google Scholar 

  98. Ortonne J-P, Lacour J-P, Vitetta A, Le Fichoux Y. Comparative study of ketoconazole 2% foaming gel and betamethasone dipropionate 0.05% lotion in the treatment of seborrhoeic dermatitis in adults. Dermatology. 1992;184(4):275–80.

    Article  CAS  PubMed  Google Scholar 

  99. Marks R, Pearse AD, Walker AP. The effects of a shampoo containing zinc pyrithione on the control of dandruff. Br J Dermatol. 1985;112(4):415–22.

    Article  CAS  PubMed  Google Scholar 

  100. Danby FW, Maddin WS, Margesson LJ, Rosenthal D. A randomized, double-blind, placebo-controlled trial of ketoconazole 2% shampoo versus selenium sulfide 2.5% shampoo in the treatment of moderate to severe dandruff. J Am Acad Dermatol. 1993;29(6):1008–12.

    Article  CAS  PubMed  Google Scholar 

  101. Papp KA, Papp A, Dahmer B, Clark CS. Single-blind, randomized controlled trial evaluating the treatment of facial seborrheic dermatitis with hydrocortisone 1% ointment compared with tacrolimus 0.1% ointment in adults. J Am Acad Dermatol. 2012;67(1):e11–5.

    Article  CAS  PubMed  Google Scholar 

  102. Warshaw EM, Wohlhuter RJ, Liu A, Zeller SA, Wenner RA, Bowers S, et al. Results of a randomized, double-blind, vehicle-controlled efficacy trial of pimecrolimus cream 1% for the treatment of moderate to severe facial seborrheic dermatitis. J Am Acad Dermatol. 2007;57(2):257–64.

    Article  PubMed  Google Scholar 

  103. Rigopoulos D, Ioannides D, Kalogeromitros D, Gregoriou S, Katsambas A. Pimecrolimus cream 1% vs. betamethasone 17-valerate 0 · 1% cream in the treatment of seborrhoeic dermatitis. A randomized open-label clinical trial. Br J Dermatol. 2004;151(5):1071–5.

    Article  CAS  PubMed  Google Scholar 

  104. Meshkinpour A, Sun J, Weinstein G. An open pilot study using tacrolimus ointment in the treatment of seborrheic dermatitis. J Am Acad Dermatol. 2003;49(1):145–7.

    Article  PubMed  Google Scholar 

  105. Shuster S, Meynadier J, Kerl H, Nolting S. Treatment and prophylaxis of seborrheic dermatitis of the scalp with antipityrosporal 1% ciclopirox shampoo. Arch Dermatol. 2005;141(1):47–52.

    Article  CAS  PubMed  Google Scholar 

  106. Dupuy P, Maurette C, Amoric JC, Chosidow O. Randomized, placebo-controlled, double-blind study on clinical efficacy of ciclopiroxolamine 1% cream in facial seborrhoeic dermatitis. Br J Dermatol. 2001;144(5):1033–7.

    Article  CAS  PubMed  Google Scholar 

  107. Satchell AC, Saurajen A, Bell C, Barnetson RS. Treatment of dandruff with 5% tea tree oil shampoo. J Am Acad Dermatol. 2002;47(6):852–5.

    Article  PubMed  Google Scholar 

  108. Seckin D, Gurbuz O, Akin O. Metronidazole 0.75% gel vs. ketoconazole 2% cream in the treatment of facial seborrheic dermatitis: a randomized, double-blind study. J Eur Acad Dermatol Venereol. 2007;21(3):345–50.

    Article  CAS  PubMed  Google Scholar 

  109. Parsad D, Pandhi R, Negi KS, Kumar B. Topical metronidazole in seborrheic dermatitis–a double-blind study. Dermatology. 2001;202(1):35–7.

    Article  CAS  PubMed  Google Scholar 

  110. [No authors listed]. A double-blind, placebo-controlled, multicenter trial of lithium succinate ointment in the treatment of seborrheic dermatitis. Efalith Multicenter Trial Group. J Am Acad Dermatol. 1992;26(3):452–7.

    Google Scholar 

  111. Segal R, David M, Ingber A, Lurie R, Sandbank M. Treatment with bifonazole shampoo for seborrhea and seborrheic dermatitis: a randomized, double-blind study. Acta Derm Venereol. 1992;72(6):454–5.

    CAS  PubMed  Google Scholar 

  112. Zienicke H, Korting HC, Braun-Falco O, Effendy I, Hagedorn M, Küchmeister B, et al. Comparative efficacy and safety of bifonazole 1% cream and the corresponding base preparation in the treatment of seborrhoeic dermatitis. Mycoses. 1993;36(9–10):325–31.

    CAS  PubMed  Google Scholar 

  113. Scaparro E, Quadri G, Virno G, Orifici C, Milani M. Evaluation of the efficacy and tolerability of oral terbinafine (Daskil®) in patients with seborrhoeic dermatitis. A multicentre, randomized, investigator-blinded, placebo-controlled trial. Br J Dermatol. 2001;144(4):854–7.

    Article  CAS  PubMed  Google Scholar 

  114. Baysal V, Yildirim M, Ozcanli C, Ceyhan AM. Itraconazole in the treatment of seborrheic dermatitis: a new treatment modality. Int J Dermatol. 2004;43(1):63–6.

    Article  CAS  PubMed  Google Scholar 

  115. Kose O, Erbil H, Gur AR. Oral itraconazole for the treatment of seborrhoeic dermatitis: an open, noncomparative trial. J Eur Acad Dermatol Venereol. 2005;19(2):172–5.

    Article  CAS  PubMed  Google Scholar 

  116. Wananukul S, Chatproedprai S, Charutragulchai W. Randomized, double-blind, split-side comparison study of moisturizer containing licochalcone vs. 1% hydrocortisone in the treatment of infantile seborrhoeic dermatitis. J Eur Acad Dermatol Venereol. 2012;26(7):894–7.

    Article  CAS  PubMed  Google Scholar 

  117. Zeharia A, Mimouni M, Fogel D. Treatment with bifonazole shampoo for scalp seborrhea in infants and young children. Pediatr Dermatol. 1996;13(2):151–3.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Dermatology, Oregon Health & Science University, Portland, OR, USA

    Eric L. Simpson

  2. Department of Dermatology, Phoenix Children’s Hospital, University of Arizona College of Medicine-Phoenix, Phoenix, AZ, USA

    Kevin B. Yarbrough

Authors
  1. Eric L. Simpson
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kevin B. Yarbrough
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Kevin B. Yarbrough .

Editor information

Editors and Affiliations

  1. Stanford University School of Medicine, Stanford, California, USA

    Joyce M.C. Teng

  2. Stanford University School of Medicine, Stanford, California, USA

    Ann L. Marqueling

  3. Pediatric Dermatology, Joe DiMaggio Children’s Hospital, Hollywood, Florida, USA

    Latanya T. Benjamin

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Simpson, E.L., Yarbrough, K.B. (2017). Atopic Dermatitis and Eczematous Eruptions. In: Teng, J., Marqueling, A., Benjamin, L. (eds) Therapy in Pediatric Dermatology. Springer, Cham. https://doi.org/10.1007/978-3-319-43630-2_3

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-43630-2_3

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-43628-9

  • Online ISBN: 978-3-319-43630-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation